Literature DB >> 8653188

Problems of using modelling in the economic evaluation of health care.

T A Sheldon.   

Abstract

Mesh:

Year:  1996        PMID: 8653188     DOI: 10.1002/(SICI)1099-1050(199601)5:1<1::AID-HEC183>3.0.CO;2-K

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


× No keyword cloud information.
  35 in total

Review 1.  Real world designs in economic evaluation. Bridging the gap between clinical research and policy-making.

Authors:  R Baltussen; R Leidl; A Ament
Journal:  Pharmacoeconomics       Date:  1999-11       Impact factor: 4.981

2.  Costs of diabetes. A methodological analysis of the literature.

Authors:  E Pagano; M Brunetti; F Tediosi; L Garattini
Journal:  Pharmacoeconomics       Date:  1999-06       Impact factor: 4.981

3.  Cost utility of drugs for multiple sclerosis. Systematic review places study in contrast.

Authors:  J Bryant; A Clegg; R Milne
Journal:  BMJ       Date:  2000-05-27

Review 4.  Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of application.

Authors:  M Sculpher; E Fenwick; K Claxton
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981

Review 5.  Modelling in health economic evaluation. What is its place? What is its value?

Authors:  A Brennan; R Akehurst
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981

Review 6.  Handling uncertainty in cost-effectiveness models.

Authors:  A H Briggs
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981

Review 7.  Testing the validity of cost-effectiveness models.

Authors:  C McCabe; S Dixon
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981

8.  Computer modelling. The need for careful evaluation and public audit.

Authors:  A Maynard; R F Cookson
Journal:  Pharmacoeconomics       Date:  1998       Impact factor: 4.981

Review 9.  The use of QALY and non-QALY measures of health-related quality of life. Assessing the state of the art.

Authors:  M Deverill; J Brazier; C Green; A Booth
Journal:  Pharmacoeconomics       Date:  1998-04       Impact factor: 4.981

10.  A proposed model for economic evaluations of major depressive disorder.

Authors:  Hossein Haji Ali Afzali; Jonathan Karnon; Jodi Gray
Journal:  Eur J Health Econ       Date:  2011-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.